PA5-78224

antibody from Invitrogen Antibodies

Targeting: VIP

Western blot (Data presented on provider website)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunohistochemistry (Data presented on provider website)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-78224

Provider

Invitrogen Antibodies

Product name

VIP Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

Positive Control: SK-N-SH , SK-N-AS, PC-3 Predicted Reactivity: Pig (100%), Sheep (100%), Rhesus Monkey (100%), Bovine (100%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

1.42 mg/mL

Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

References

Submitted references

Activation of the anterior cingulate cortex ameliorates anxiety in a preclinical model of fetal alcohol spectrum disorders.

Hwang HM, Hashimoto-Torii K
Translational psychiatry 2022 Jan 20;12(1):24

---

VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD).

Semaniakou A, Chappe F, Anini Y, Chappe V
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2021 Sep;20(5):881-890

---

Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues.

Ang G, Brown LA, Tam SKE, Davies KE, Foster RG, Harrison PJ, Sprengel R, Vyazovskiy VV, Oliver PL, Bannerman DM, Peirson SN
Translational psychiatry 2021 Nov 15;11(1):588

Immunocytochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunocytochemistry-Immunofluorescence analysis of VIP was performed in DIV9 rat E18 primary hippocampal neuron cells fixed in 4% paraformaldehyde at RT for 15 min. Green: VIP Polyclonal Antibody (Product # PA5-78224) diluted at 1:500. Red: beta Tubulin 3/ Tuj1, stained by beta Tubulin 3/ Tuj1 antibody. Blue: Fluoroshield with DAPI.

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Fig. 4 Immunofluorescence cFos, VIP, and AVP signals. a A schematic depicting the timeline of the experiment: For half of the animals ( n = 3 wild-type and three GluA1 KO mice), no light pulse was given prior to perfusion and they were perfused at ~ZT15.5 (day 1, LP -); the remaining animals perfused on day 2 ( n = 3 wild-type and three GluA1 KO mice) received a nocturnal light pulse ( LP +) which started at ZT14. Star symbols indicate the Zeitgeber time of perfusion, which was ~90 min after the onset of the nocturnal light (~ZT15.5). Thus, the ZTs at which perfusion was performed were matched between LP - and LP + conditions. b Representative images of immunofluorescence cFos, VIP, and AVP staining in the SCN (scale bar = 100 mum). In the middle multi-panels, brighter colours indicate higher immunofluorescence ( F ) intensity, whereas darker colours indicate lower F intensity. A schematic delineating the core (ventromedial) vs. shell (dorsolateral) subregions of the SCN is shown on the right (D dorsal, V ventral, M medial, and L lateral). c Mean F intensities (+-standard errors of the mean) from all three channels across the entire mediolateral extent of the SCN. Nocturnal-light-induced cFos signals were attenuated in GluA1 knockouts (*two-way ANOVA for LP + conditions, Genotype x Mediolateral Extent interaction p = 0.019). VIP and AVP data were pooled across LP - and + LP ( n = 6 per genotype). The vertical dashed lines represent the location of the midline, and the 60-mum